Surrogate endpoints are crucial in cancer research and treatment development for several reasons:
Time Efficiency: They can provide early indications of a treatment's effectiveness, allowing quicker decision-making. Resource Utilization: They help in conserving resources by shortening trial durations and reducing costs. Ethical Considerations: They allow for faster patient access to potentially life-saving treatments.